In this review
The first bill needs an explanation, not an average
MangoRx Slim combines semaglutide and vitamin B6 in a mint-flavored dissolving tablet. The product page displays $299 monthly, but the weight-care page shows $67 monthly and describes a thirty-day pack. Neither display explains how it reconciles with the other. Do not treat the lower figure as a confirmed purchase or average the two. [1] [2]
This belongs on a comparison list for a reader discussing a needle-free prescription, with one condition: the selected quote must name the formulation, amount, first payment and refill charge. A monthly payment is useful information only when it buys the same product being evaluated.
Keep the actual first bill and renewal separate in the complete GLP-1 cost planner.
For a different billing-period qualifier rather than a dissolving-tablet offer, read our Enhance MD plan-and-billing review.
A dissolving tablet is a different evidence question
The page promotes fewer side effects from adding B6 and a mechanism shared with injectable GLP-1 treatment. Those statements do not establish comparable absorption, weight change or nausea rates for this preparation. MangoRx’s own footer cautions that approved-product data may not apply to compounded drugs. [1] [5]
Slim is not made equivalent to an approved oral semaglutide medicine by being taken through the mouth. FDA distinguishes compounded drugs from approved generics. A preference against needles can matter in a clinical discussion, but the clinician still needs a product-specific rationale rather than a percentage borrowed from an injection trial. [6]
See why an ingredient-only comparison misses the exact products and population in SURPASS-2.
The free-consultation headline has a financial exception
The site advertises free provider visits. Its refund policy nevertheless says a buyer found unsuitable for GLP-1 care after an appointment may pay $80 for video or $70 for a phone consultation. It also describes an $80 late-cancellation or possible no-show fee, with twenty-four hours’ appointment notice. Confirm which process and charges apply before booking. [3] [5]
That appointment deadline is separate from stopping a medication renewal. The general terms require cancellation at least forty-eight hours before renewal. The product’s cancel-anytime wording should not be taken to mean a refill can always be reversed after processing starts. [1] [4]
Compare a different notice period and purchase qualifier in our Healthon fee-and-notice review.
The order and the clinical relationship have separate limits
The terms describe MangoRx as a platform, name Epiq Scripts in fulfillment and reserve prescribing for independent providers. They contain inconsistent pharmacy-choice wording: one passage permits preferred pharmacies, another waives that choice. Settle the actual dispenser and transfer conditions for the prescription rather than infer them from a licensing badge. [4]
The general terms say sales are final; the refund page gives limited prescription-error and pre-fill exceptions. Neither establishes an outcome guarantee. Choose Slim only after the clinical explanation, full quote and usable follow-up justify this formulation. If those answers are missing, compare a different care arrangement before beginning a recurring payment. [3] [4]
Identify which organization supplies each part of care using our clinic-versus-pharmacy-access comparison.
Understanding the cost
Slim product page displays $299/month; weight-loss page displays $67/month without a reconciled selected-plan explanation. Refund policy lists conditional $80 video/$70 phone charges if GLP-1 care is unsuitable, plus late-cancellation fees. Confirm the selected plan’s complete invoice and renewal.
Build your cost estimateSources
- MangoRx: Slim dissolving semaglutide and B6 product, monthly offer and safety information
- MangoRx: weight-care page, thirty-day tablet supply and separate starting display
- MangoRx: prescription refunds, consultation charges and appointment cancellation policy
- MangoRx: recurring payment cutoff, clinical and pharmacy roles and final-sale terms
- MangoRx: treatment catalog and compounded-product disclosure
- FDA: compounding, premarket review and the distinction from generics
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.